●Prognostic effect of subsequent childbirth after the diagnosis of breast cancer using propensity score matching analysis ●HER2-positive invasive lobular carcinoma: a rare breast cancer which may not necessarily require anti-HER2 therapy. A population-based study...
Cancer Drugs 2024,CanadaWomens Health 2025,Canada BREAST PATHOLOGY-2024 About Conference Sessions/ Tracks Market Analysis About Conference We would be glad to welcome you all to attend the 5th International Conference on Breast Pathology and Cancer Diagnosis going to be held at Amsterdam, Netherlands ...
中国抗癌协会乳腺癌诊治指南与规范(2024年版)Guidelines for breast cancer diagnosis and treatment by China Anti-cancer Association (2024 edition)doi:10.19401/j.cnki.1007-3639.2023.12.004乳腺癌,诊断,治疗,指南中国抗癌协会乳腺癌专业委员会中华医学会肿瘤学分会乳腺肿瘤学组...
Breast cancer is the most prevalent kind of cancer among women and there is a need for a reliable algorithm to predict its prognosis. Previous studies focused on using gene expression data to build predictive models. However, recent advancements have mad
Abbreviations: ABC: advanced breast cancer; HER2: human epidermal growth factor receptor 2. 4. Treatment of unresectable locally advanced breast cancer Approximately 20% of breast cancer cases are locally advanced breast cancer without distal metastasis upon initial diagnosis.19 Biopsy and histology exami...
Nurses also support patients emotionally, addressing the mental health challenges that come with a breast cancer diagnosis. Related Associations: British Association of Breast Cancer Surgeons | Society of Breast Cancer Surgeons of the Netherlands | German Breast Cancer Association | Asian Association of ...
Discrimination, calibration and clinical usefulness of the nomogram for predicting breast cancer were assessed in the validation group. The radiomics score included 9 selected radiomics features. The radiomics score and BI-RADS category were independently associated with breast malignancy. The nomogram ...
美国NCT数据库提供标题为Diagnosis Value of SEMA4C in Breast Cancer的临床试验登记信息,包括基本信息,试验详情,试验设计,试验分组,治疗终点,招募标准,联系人与地点等.
The FDA expanded the approval of trastuzumab deruxtecan for treatment of breast cancer. January 24, 2025 5 min read Save Q&A: Oncofertility innovator awarded National Medal of Science Few researchers can claim to be a pioneer in their field quite like Teresa K. Woodruff,...
Between 30% and 70% of patients with breast cancer have pre-existing chronic conditions, and more than half are on long-term non-cancer medication at the time of diagnosis. Preliminary epidemiological evidence suggests that some non-cancer medications ma